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Mads Henrik Strand Moxness1 and Ståle Nordgård2,3,4*Abstract
Background: The objective of this observational study was to evaluate the outcomes of intranasal surgery in
patients with obstructive sleep apnea (OSA) in a single institution in Norway.
Methods: Fifty-nine patients with OSA and clinically significant nasal obstruction underwent either septoplasty
alone or septoplasty with concomitant volume reduction of the turbinates from August 2008 until the end of
December 2010. Subjects were scheduled for sleep polygraphy before and 3 months after treatment.
In this observational single-centre cohort study we evaluated and compared the effect of these two specific surgical
procedures on sleep related parameters.
Results: There was a significant reduction in the apnea-hypopnea index (AHI) only in the group that had
septoplasty with turbinate reduction (17.4, (SD 14.4) – 11.7, (SD 8.2), p <0.01), and this effect was significantly better
than in the group treated with septoplasty alone. Other objective parameters remained unchanged. Subjective
assessments obtained with a postoperative questionnaire showed an equally positive effect on diurnal sleepiness
and nasal obstruction in both groups, and a better effect on sleep quality in the combined treatment group.
Conclusion: The effect of nasal surgery on obstructive sleep apnea seemed to be greater when there were
indications for combined surgery of the inferior turbinates and the nasal septum, compared to when there were
indications for septoplasty alone.
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There is growing interest in the field of sleep-related dis-
orders (SRD) and in obstructive sleep apnea (OSA) par-
ticularly. This is due to the impact of SRD on global
health, and a result of more profound insight into the ef-
fects of sleep deprivation, and the biomechanical and
physiological changes that occur during the development
of upper airway collapse during sleep [1]. The traditional
way of understanding the collapsing airway includes both
theories of neuromuscular regulation [2] and theories of* Correspondence: stale.nordgard@ntnu.no
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article, unless otherwise stated.fluid structure interaction [3]. Surgical treatments for OSA
have been performed in several forms over the last 3 de-
cades [4]. To date, tracheotomy is the only surgical pro-
cedure with definite and lasting success, but it is regarded
as a method with unwanted side effects. Multiple level sur-
gery has gained support, as well as maxillomandibular sur-
gery, but these are also major procedures and the same
concerns regarding morbidity apply for these. The effect of
limited and less extensive surgery of the upper airways still
needs evaluation regarding selection of procedure and
results. Nasal surgery has been performed extensively in
these patients, often with good effect on quality of life
(QOL) measures [5,6]. Still, there is no conclusive evidence
of clinical effect, and the different nasal procedures
performed are often quite randomly chosen. To oured Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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pare the results of different nasal procedures for nasal
obstruction in patients with OSA. We have evaluated
and compared the results of two specific surgical proce-
dures in the nasal cavity, septoplasty alone and septo-
plasty with simultaneous turbinate volume reduction.
Methods
This study was an observational single-centre cohort
study. It was approved by the national regional ethics
committee and was registered in Clincaltrials.gov.
(NCT01282125). Between August 2008 and December
2010, 78 patients with OSA were treated surgically for
nasal obstruction in Aleris Hospital in Trondheim,
Norway. Fifty-nine of these had been treated with septo-
plasty alone or septoplasty combined with volume re-
ductive surgery of the turbinates. Group 1 (n = 33)
consisted of patients who had undergone septoplasty
alone, and group 2 (n = 26) of patients treated with com-
bined septoplasty and volume reductive surgery. The
remaining patients underwent rhinoseptoplasties (n = 8),
functional endoscopic sinus surgery (n = 4) and turbinate
resection (n = 7) as single procedures, but the groups
were too small to be subanalyzed. All patients in the two
analyzed groups underwent traditional cartilage preserv-
ing septoplasty under general anesthesia. The volume re-
ductive surgery comprised radiofrequency tissue ablation
(n = 10) (BM 780-II, Sutter Medizintechnik Gmbh), lat-
eral fracture of the lower turbinate (n = 15), and surgical
reduction of concha bullosa (n = 1).
The patients were referred to the sleep clinic for sus-
pected OSA from either primary care physicians or ENT
specialists within a specific geographical area. All pa-
tients underwent a nocturnal sleep evaluation with an
Embletta™ Portable Diagnostic System (ResMed, San
Diego, California, USA) or a Reggie polygraph (Camtech,
Oslo, Norway) and a clinical examination. There were
no prior history of nasal surgery or prolonged use of
nasal steroids. None of the patients were diagnosed with
chronic rhinosinusitis or enlarged adenoids. Patients
with confirmed OSA and clinically significant nasal ob-
struction due to a septal deviation with or without
hypertrophy of turbinates were offered intranasal surgery
as a first line of treatment. The decision to supplement
septoplasty with volume reductive surgery in selected
patients was based on the clinical evaluation, and not
supported by objective measurements. If there were a
coherence between the patients complaints of nasal
blockage on both sides, and there was obvious swelling
of the inferior turbinates that was relieved after decon-
gestion with tetracain/adrenalin over 5-10 minutes in
the office, one would recommend that turbinate reduc-
tion should be performed at the time of the septal sur-
gery. Only patients with apnea-hypopnea index (AHI) >5and BMI <35 were included. All patients used saline irri-
gation 6-8 times a day for two weeks postoperatively. No
intranasal steroids were administered. Optional pain re-
lief was 50 mg of diclofenac sodium three times a day
and 30-60 mg of codein phosphate in combination with
500 mg of paracetamol. The same surgeon (MM) treated
all but one patient. The patients were informed of the
possibility of crusting in the nose for a period up to
three weeks after surgery, but there were no postopera-
tive infections and no necrosis or loss of nasal function
at the follow up three months later.
The effects of intranasal surgery on OSA were evalu-
ated routinely after 3 months with a repeated polygraph.
Subjective assessment of daytime sleepiness was evalu-
ated using the Epworth Sleepiness Scale (ESS) preopera-
tively and 3 months postoperatively. In a dichotomous
questionnaire, the patients were asked to evaluate the ef-
fects of surgery on nasal obstruction and the subjective
quality of sleep. At the same time a written informed
consent was obtained from all the participants. The al-
ternatives in the questionnaire were: 1. Did you experi-
ence an effect on your nasal obstruction after surgery?
Yes or No. 2. Did you experience an effect on your sleep
quality after surgery? Yes or No. If patients reported a
positive outcome, they were asked to supplement
the answer with a visual analog scale (VAS) in which
their agreement of surgical effect was graded in a con-
tinuous scale ranging from 0 = no agreement to 10 = full
agreement. Scores between 0-3 were defined as “mild”,
scores >3-7 were defined as “moderate”, and scores >7-
10 were considered “good” [7]. The primary outcome
was alterations in the AHI, oxygen desaturation index
(ODI), body mass index (BMI) and Epworth Sleepiness
Scale (ESS) in the two groups. The secondary outcome
was to evaluate the effect of surgery on sleep quality and
nasal obstruction reported in the questionnaire. SPSS
19.0 was used for the statistical evaluations. Preoperative
and postoperative values were evaluated using the Wil-
coxon matched-pairs test in continuous variables with-
out normal distribution (ODI, ESS). Variables with
normal distribution (BMI, AHI) were evaluated using
the paired t-test. The values for AHI were transformed
using natural logarithm in order to create a normal dis-
tribution. An independent t-test was used to compare
the changes of the objective measures and VAS after
surgery between group 1 and 2. Differences with p <0.05
were considered significant.
Results
In both groups, there was a predominance of males
(97% in group 1 and 85% in group 2), and the mean age
was 47.5 (30 – 68) in group 1 and 45.3 (23 - 68) in
group 2. The groups did not differ significantly regarding
preoperative AHI, ODI, ESS, Mallampati score, age,
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parameters before and after surgery in three ways: the
overall changes in both groups pooled together, changes
within each group, and the changes in the mean differ-
ence between the groups (Table 1). Overall, in both
groups together, there was no significant reduction in
mean AHI after surgery: 18.1 (±13.7) - 16.6 (±12.9), (95%
CI -1.84, 4.83), p = 0.365, mean ODI: 14.2 (±12.3) – 12.4
(±10.7), (95% CI -1.16, 4.75), p = 0.229 or mean BMI: 28.1
(±3.2) – 28.3 (±3.0), (95% CI – 0.673, 0.285), p = 0.422.
The reduction in mean ESS, however, was highly statis-
tically significant: 10.7 (±3.7) – 8.9 (±3.8), (CI 1.00,
2.61), p <0.001. In comparison, when we looked at each
group separately, we found a significant reduction in
group 2 in mean AHI: 17.4 (±14.4) – 11.7 (±8.2), (95% CI
0.004, 0.006), p = 0.007 and mean ESS: 9.7 (±3.4) – 7.6
(±2.2), (95% CI 0.004, 0.006), p = 0.006. In group 1
there was no significant reduction in mean AHI, ODI
or BMI after surgery, but there was a significant reduc-
tion in the mean ESS score: 11.5 (±3.7) – 10.0 (±4.5),
(95% CI 0.53, 2.54), p = 0.004. The changes in meanTable 1 Baseline values and postoperative values
Surgery
Septoplasty Septoplasty
and volume
reduction
Overall
results
Preoperative values Mean SD Mean SD Mean SD
AHI 18.75 13.36 17.39 14.38 18.15 13.71
ODI 14.29 12.00 14.12 12.73 14.21 12.22
ESS 11.54 3.72 9.74 3.42 10.74 3.67
BMI 28.33 3.40 27.80 3.05 28.10 3.23
Postoperative values Mean SD Mean SD Mean SD
AHI 20.46 14.64 11.70 8.19 16.60 12.90
ODI 14.87 12.25 9.30 7.36 12.42 10.67
ESS 10.00 4.51 7.59 2.18 8.94 3.84
BMI 28.69 3.12 27.77 2.70 28.28 2.95
P-values of the difference
AHI 0.273 0.007 0.365
ODI 0.671 0.064 0.229
ESS 0.004 0.006 <0.001
BMI 0.202 0.716 0.422
P-values of the difference
between treatment groups
AHI 0.029
ODI 0.069
ESS 0.454
BMI 0.429
There are no significant differences at baseline between the groups. There is a
significant reduction of AHI between the two surgery groups.ODI levels did not fall below the 0.05 level of signifi-
cance in either category, although there were near sig-
nificant values in group 2. The reduction in the difference
of mean AHI after surgery was significant between the
groups: 1,7 (±8,8) – 5,7 (±16,1), (95% CI 0.8, 14.0), p =
0.029, but the effects on ESS, ODI and BMI were not sig-
nificant between the two groups . Success criteria defined
as a postoperative drop in AHI <20 and/or 50% reduction
in AHI [8] were met by 15.2% (5/33) in group 1, and by
27% (7/26) in group 2, but the difference in surgical suc-
cess was not statistically significant. There were 76% ques-
tionnaire responders in group 1 and 77% in group 2. In
group 1, 96% answered that the procedure was effective
with regard to nasal obstruction, and 68% that it improved
their quality of sleep. In group 2 the corresponding per-
centages were 85% and 80%. The difference between the
groups was not statistically significant. A significantly lar-
ger proportion in group 2 reported a good improvement
in sleep quality: mean 0.08 (±0.27) – mean 0.35 (±0.49),
(95% CI 0.037, 0.503), p = 0.024 (Figure 1).
Discussion
Intranasal surgery is currently regarded as important in
order to improve compliance with treatment using nasal
continuous positive airway pressure (CPAP)/bilevel posi-
tive airway pressure (BiPAP) devices in patients with
OSA. The impact of intranasal surgery on objective
measurements in OSA patients is unclear, but is
regarded as limited, as shown by Verse et al in 2002 [9].
In a rare blinded randomized controlled study with
sham surgery (septal resection +/- turbinectomies) in
2008, Koutserelakis et al [10] found responders only in
the real surgery group. They concluded that nasal sur-
gery rarely treats OSA effectively. In a meta-analysis of
13 studies that dealt with nasal surgery alone in OSA pa-
tients [11], the reviewers concluded that nasal surgery
for obstruction alone does not reduce AHI significantly
but ameliorates daytime sleepiness and clinical symp-
toms of snoring. Only one of these studies described a
statistically significant reduction in AHI [12]. However,
the observation period in this study was only 1 month as
opposed to 3 months in ours, and the study group was
mixed and underwent either septal resection alone or
combined with turbinate surgery. One study by Li et al
[13] described a homogenous patient group comparable
to ours with septal deviation and hypertrophic inferior tur-
binates (n = 44). They found no significant effect of surgery
on AHI, and a lower success rate of 16%. The procedure
differed somewhat from ours in that only septal resections
were performed under local anesthesia. It may indicate
that the impact of the septal deviation on nasal obstruction
preoperatively or postoperatively differs from that in our
study. In surgical practice different nasal procedures are
often performed simultaneously, and previous clinical
Figure 1 The self-reported improvement of sleep quality after surgery. The improvement (VAS sleep) described as mild, moderate or good.
The values for septoplasty in blue (left) and the values for septoplasty and volumereduction of the inferior turbinates in green (right).
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had presented the results pooled as a single study
group, without a comparison of the two different surgi-
cal approaches, we would have missed the statistically
significant improvement in patients with combined sur-
gical treatment. Assessments of the overall effect of
nasal surgery on OSA predict that 16.7% will have a re-
duction in AHI [10] that meets the criteria by Sher
[8,9]. In this observational study, we singled out two
different intranasal surgical procedures for comparison
and found that there were statistical differences in the
outcome of AHI between septoplasty alone and septo-
plasty combined with volume reductive surgery in OSA
patients. Using the same Sher criteria, we found a near
twofold increase in treatment success in the combined
surgery group compared with the septoplasty group.
This difference did not reach statistical significance but
it is possible that it would do so in a larger study group
as the difference in AHI reduction was significant. One
might anticipate that the better effect on OSA might be
due to a larger effect on nasal obstruction in patients in
need of combined surgery. It is also possible that the
additional inferior turbinate hypertrophy affected the
laminar airflow and pharyngeal walls negatively to a
higher degree, and hence this group achieved a better
result after surgery. Li et al [13] found that patients with
a low Friedman tongue position had better results fromnasal surgery and Morinaga et al reported less effect in
patients with a narrow retroglossal space and high
Mallampati score. It may indicate that the increased con-
tribution of pharyngeal structures to OSA will worsen the
final results as the percentage of the nasal obstruction is
diminished. On the other hand, it may also indicate that
the effect of surgery was better for patients with concomi-
tant increased volume of the turbinates and septal devi-
ation because the total contribution of the nasal
obstruction to OSA development may have been greater
than in patients with septal deviation alone.
In this observational study, there are some limitations
that should be taken into consideration. The number of
patients in group 2 is low and could represent a statis-
tical uncertainty. There is a higher night-to-night sleep
polygraph variation regarding AHI in mild or moderate
sleep apnea than in severe apnea that may influence
the results on an individual basis [16]. This might sug-
gest that a follow-up study should be performed in pa-
tients for whom there is a discrepancy between
subjective and objective results. Furthermore, there is a
lack of objective measuring of nasal obstruction in an
outpatient setting that would otherwise help the sur-
geon in deciding which type of surgery to perform. Our
study is an observational cohort study, and the patients
were therefore not randomized to specific treatment
groups. As a result, we cannot conclude that combined
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with clinical indications for septal surgery. There may
also be possible side effects of supplementing volume
reductive surgery in all OSA patients with septal de-
formities, and this approach should be avoided. How-
ever, the results for OSA in our material seemed to be
better when both turbinate hypertrophy and septal de-
viation were treated. Even though combined surgery
does not imply a cure for the majority of the patients,
there was a reduction of symptoms, verified by the
questionnaire, which indicates that 80% perceived an
improvement in their quality of sleep after the com-
bined surgery. This study then supports the view that
an effect on daytime sleepiness is observed more often
than on obstructive apnea and hence that nasal surgery
alone is best suited for patients with mild or moderate
obstructive sleep apnea. As long as we do not have any
single treatment that provides a cure for OSA and not
all patients with mild and moderate OSA will accept or
tolerate CPAP or oral devices, there will be a place for
targeted surgical treatments that improve QOL in these
patients.
Conclusion
In this observational cohort study, the effect on AHI
was significantly better when indication for septoplasty
combined with surgery of the inferior turbinates was
present, compared to septoplasty alone. The overall ef-
fect in both groups pooled together showed no signifi-
cant effect on reduction of the objective parameters but
a significant reduction in the subjective ESS score. This
implies that intranasal surgery has a good effect on the
subjective quality of sleep in OSA patients, and that
there might be an added effect on AHI in selected pa-
tients with both septal deviation and hypertrophy of the
inferior turbinates. Future randomized and prospective
studies that can identify responders to nasal surgery as
well as what type of intranasal surgery needed.
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